BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37992627)

  • 1. Impact of systematic dynamic maneuvers during computed tomography scan on the T classification of head and neck cancers.
    Ait Idir M; Trinh JM; Chanson A; Salleron J; Henrot P
    Clin Imaging; 2024 Jan; 105():110023. PubMed ID: 37992627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of chest CT scan for head and neck cancer.
    Fukuhara T; Fujiwara K; Fujii T; Takeda K; Matsuda E; Hasegawa K; Nomura K; Kitano H
    Auris Nasus Larynx; 2015 Feb; 42(1):49-52. PubMed ID: 25239083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The validation of low-dose CT scans from the [
    Zwart AT; Cavalheiro VJ; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1735-1742. PubMed ID: 36781423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
    Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation.
    Liu JC; Bhayani M; Kuchta K; Galloway T; Fundakowski C
    Oral Oncol; 2019 Jan; 88():131-136. PubMed ID: 30616783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Katsuragawa S; Shiraishi S; Toya R; Tashiro K; Kawanaka K; Oya N; Tomiguchi S; Yamashita Y
    Acta Radiol; 2008 Jul; 49(6):693-9. PubMed ID: 18568563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Deep Learning to Augment Image-Guided Radiotherapy for Head and Neck and Prostate Cancers.
    Oktay O; Nanavati J; Schwaighofer A; Carter D; Bristow M; Tanno R; Jena R; Barnett G; Noble D; Rimmer Y; Glocker B; O'Hara K; Bishop C; Alvarez-Valle J; Nori A
    JAMA Netw Open; 2020 Nov; 3(11):e2027426. PubMed ID: 33252691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep learning based time-to-event analysis with PET, CT and joint PET/CT for head and neck cancer prognosis.
    Wang Y; Lombardo E; Avanzo M; Zschaek S; Weingärtner J; Holzgreve A; Albert NL; Marschner S; Fanetti G; Franchin G; Stancanello J; Walter F; Corradini S; Niyazi M; Lang J; Belka C; Riboldi M; Kurz C; Landry G
    Comput Methods Programs Biomed; 2022 Jul; 222():106948. PubMed ID: 35752119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
    Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM
    Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.
    Gregor RT; Valdés-Olmos R; Koops W; Balm AJ; Hilgers FJ; Hoefnagel CA
    Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):509-14. PubMed ID: 8615968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
    Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.
    Hsu D; Rath TJ; Branstetter BF; Anzai Y; Phillips CD; Juliano AF; Mosier KM; Bazylewicz MP; Poliashenko SM; Kulzer MH; Rhyner PA; Risk B; Wiggins RH; Aiken AH
    Radiol Imaging Cancer; 2021 May; 3(3):e200131. PubMed ID: 34018845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck cancers on CT: preliminary study of treatment response assessment based on computerized volume analysis.
    Hadjiiski L; Mukherji SK; Ibrahim M; Sahiner B; Gujar SK; Moyer J; Chan HP
    AJR Am J Roentgenol; 2010 Apr; 194(4):1083-9. PubMed ID: 20308515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pre-therapeutic imaging work-up in the staging of endometrial cancer: Interest in a systematic second opinion in a cancer center.
    Baijnath P; Pelissier M; Sahki N; Henrot P
    J Gynecol Obstet Hum Reprod; 2024 Feb; 53(2):102716. PubMed ID: 38142752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Smee R; Moses D; Bauer J
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PET-CT, CT and MRI scan in initial staging and management of head and neck cancers.
    Ahmad S; Mair M; Haris PA; Haider A; Baker A; Conboy P; Walter H; Raj L; Wright S; Vaidhyanath R; Thiagarajan S
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2651-2656. PubMed ID: 34546395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of image noise levels, scout scan dose and lens shield on image quality and radiation exposure in z-axis dose-modulated neck MSCT on 16- and 64-slice Toshiba Aquilion scanners.
    Bauknecht HC; Jach C; Bohner G; Meyer H; Scheurig C; Siebert E; Klingebiel R
    Eur J Radiol; 2010 Feb; 73(2):439-43. PubMed ID: 19135816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
    Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR
    AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.